Literature DB >> 25540194

The importance of pharmacist providing patient education in oncology.

Mia Avery1, Felecia Williams2.   

Abstract

The world's increasing diversity requires health care professionals to adjust delivery methods of teaching to accommodate different cultural values and beliefs. The ability to communicate effectively across languages and various cultural practices directly affects patient education outcomes. Pharmacist should be aware of varying modalities and considerations when counseling a patient diagnosed with cancer and undergoing chemotherapy. In more recent years, the medical profession has seen an increase in patient outcomes due to using the multidisciplinary team approach and has benefited by implementing Medication Therapy Management (MTM) programs at various institutions. For the clinical pharmacist, this would mean documentation for these services should be precise and accurate based on the specific patients needs. There are several factors involved in the care and therapy of the patient with cancer. Clinical oncology pharmacist should be aware of the ever-changing role in oncology and be able to implement new practices at their facility for better patient outcomes.
© The Author(s) 2014.

Entities:  

Keywords:  Medication Therapy Management; clinical pharmacist; counseling; education; oncology

Mesh:

Substances:

Year:  2014        PMID: 25540194     DOI: 10.1177/0897190014562382

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  6 in total

Review 1.  The need for community pharmacists in oncology outpatient care: a systematic review.

Authors:  Johannes Thoma; Romána Zelkó; Balázs Hankó
Journal:  Int J Clin Pharm       Date:  2016-04-07

Review 2.  A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.

Authors:  Andrew M Whitman; Kathlene A DeGregory; Amy L Morris; Erika E Ramsdale
Journal:  Oncologist       Date:  2016-05-05

3.  Supportive Care Organization in France: a national in-depth survey among patients and oncologists.

Authors:  Florian Scotté; Christian Hervé; Pauline Leroy; Jean-Marc Tourani; René-Jean Bensadoun; Marie-Eve Bugat; Fadila Farsi; Nicolas Jovenin; Moïse Namer; Christophe Tournigand; Sophie Morin; Cloé Brami; Stéphane Oudard; Alexandre Saadi; Ivan Krakowski
Journal:  Support Care Cancer       Date:  2017-02-20       Impact factor: 3.603

4.  Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations.

Authors:  Gennaro A Paolella; Andrew D Boyd; Scott M Wirth; Sandra Cuellar; Neeta K Venepalli; Stephanie Y Crawford
Journal:  Pharmacy (Basel)       Date:  2018-03-08

5.  2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard.

Authors:  Emily Mackler; Eve M Segal; Benyam Muluneh; Kate Jeffers; Jenna Carmichael
Journal:  J Oncol Pract       Date:  2019-03-12       Impact factor: 3.840

6.  Effects of Counselling on Quality of Life among Cancer Patients in Malaysia: A Randomized Controlled Trial.

Authors:  Ummavathy Periasamy; Sherina Mohd-Sidik; Mehrnoosh Akhtari-Zavare; Lekhraj Rampal; Siti Irma Fadhilah Ismail; Rozi Mahmud
Journal:  Iran J Public Health       Date:  2020-10       Impact factor: 1.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.